Potentially inadequate medication in patients with myasthenia gravis

Potentially inadequate medication in patients with myasthenia gravis - PIM in Myasthenia gravis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00033635

Enrollment

Registered

2024-02-16

Start date

2022-04-22

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G70.0

Interventions

Group 1: If the patient consents, they are asked to complete a questionnaire regarding potentially inadequate medication. In addition, a detailed medication history is taken, including medication take

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: -Patients with clinically and instrumentally verified MG - = 18 years of age - Ability to consent or legal guardian with court authorisation for the area of responsibility

Exclusion criteria

Exclusion criteria: - Patients with unclear neuromuscular disease without the fulfilment of clinically and clinically and instrumentally definitive signs of MG - <18 years of age - Patient incapable of giving consent with a carer, without judicial authorisation for the area of responsibility

Design outcomes

Primary

Measure	Time frame
The proportion of potentially inadequate medication in patients with myasthenia gravis and the risk factors for the occurrence of these medications.	—

Secondary

Measure	Time frame
- Clinical outcome of patients with potentially inadequate medication. - Relevance of potentially inadequate treatment in our cohort. - The level of patient education regarding medication and potentially inadequate medication.	—

Countries

Germany

Contacts

Public ContactJana Zschüntzsch

Universitätsmedizin Göttingen

j.zschuentzsch@med.uni-goettingen.de+49 551 3914139

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026